Encrypted | Login

Task Group No. 378 - Safety, treatment planning, and quantitative pre- and post-treatment imaging and dosimetry for hepatic yttrium-90 microsphere therapy (TG378)

AAPM Members, Affiliates and Non-Member Affiliates - Login for access to additional information

Charge
  1. Provide summarized statements on the knowledge and rationale for yttrium-90 (Y-90) microsphere therapy.  Review articles and supporting articles will be discussed.
  2. Review current Y-90 microsphere therapy clinical practices and recommend measures for standardization in treatment planning (with emphasis on dosimetry, including but not limited to voxel-based treatment planning) and imaging protocols.
  3. Provide expert commentary of recently developed scientific and clinical topics, such as quantitative pre- and post-treatment imaging and dosimetry, including imaging surrogates and their validity.
  4. Discussion of future directions of the modality within scope of published research and development to date.
By-Laws:Not Referenced.Rules: Not Referenced.
Approved Date(s):3/21/2022 - 12/31/2023
Reviewable Draft Deadline:
Committee Keywords: No Keywords Entered

Board of Directors
Science Council
Therapy Physics Cmte  [Status]
Working Group on Radioactive Microspheres  [Status]
TG378 - Safety, treatment planning, and quantitative pre- and post-treatment imaging and dosimetry for hepatic yttrium-90 microsphere therapy  [Status]

» Conflict of Interest report for TG378
» Status Reports for Task Groups -
AC | EC | IC | PC | SC | Board Committees | All
Chair

Diane Alvarez
Task Group Chair

2022 Roster

(dates shown below are start and end dates of position.)

=complete and up-to-date, =incomplete conflict of interest statement.
VOTING AppointmentsThere are 10 voting members.

up-to-dateShirin Abbasinejad Enger

3/21/2022 - 12/31/2023 Member

up-to-dateDiane Alvarez, MS

3/21/2022 - 12/31/2023 Task Group Chair

up-to-dateWilliam A. Dezarn, PhD

3/21/2022 - 12/31/2023 Member

up-to-dateVanessa L. Gates, MS

3/21/2022 - 12/31/2023 Member

up-to-dateStephen A. Graves Ph.D.

3/21/2022 - 12/31/2023 Member

up-to-dateRobert F. Hobbs, PhD

3/21/2022 - 12/31/2023 Member

up-to-dateSrinivas Cheenu Kappadath, PhD

3/21/2022 - 12/31/2023 Member

up-to-dateNichole M. Maughan, PhD

3/21/2022 - 12/31/2023 Member

up-to-dateReed G. Selwyn, PhD

3/21/2022 - 12/31/2023 Member

up-to-dateWendy Siman, PhD

3/21/2022 - 12/31/2023 Task Group Vice Chair
NON-VOTING AppointmentsThere are 6 non-voting members and guests.

up-to-dateNadine Abi-Jaoudeh

3/21/2022 - 12/31/2023 Consultant (nonvoting)

up-to-dateJanice M. Campbell, PhD

3/21/2022 - 12/31/2023 Consultant (nonvoting)

up-to-dateJeffrey Cessna

3/21/2022 - 12/31/2023 Consultant (nonvoting)

up-to-dateAndrew S. Kennedy

3/21/2022 - 12/31/2023 Consultant (nonvoting)

up-to-dateS. P. Kim, MEng

3/21/2022 - 12/31/2023 Consultant (nonvoting)

up-to-dateRobert Lewandowski, Physician

3/21/2022 - 12/31/2023 Consultant (nonvoting)
HQ Team Appointed to CommitteeThere are 0 staff.



See connections to Task Group No. 378 - Safety, treatment planning, and quantitative pre- and post-